Search Results - "Khandave, Suhas S"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Comparative bioequivalence studies of tramadol hydrochloride sustained-release 200 mg tablets

    Comparative bioequivalence studies of tramadol hydrochloride sustained-release 200 mg tablets by Khandave, Suhas S, Sawant, Satish V, Joshi, Santosh S, Bansal, Yatish K, Kadam, Sonal S

    Published in Drug design, development and therapy (25-11-2010)
    “…Tramadol hydrochloride is available as 50 mg immediate-release (IR) and 100 mg, 200 mg, and 300 mg sustained-release (SR) tablets. The recommended dose of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Comparative pharmacokinetic and pharmacodynamic evaluation between a new biosimilar and reference recombinant human growth hormone

    Comparative pharmacokinetic and pharmacodynamic evaluation between a new biosimilar and reference recombinant human growth hormone by Toffoletto, Odaly, Afiune, Jorge, Thiemann, Josef Ernst, Khandave, Suhas S, Patel, Swati, Rodrigues, Debora G

    Published in Growth hormone & IGF research (01-10-2016)
    “…Abstract Objective To extend available dosing options in the treatment of growth hormone deficiency, a comparative pharmacokinetic and pharmacodynamic phase-1…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Bioequivalence study of two losartan tablet formulations with special emphasis on cardiac safety

    Bioequivalence study of two losartan tablet formulations with special emphasis on cardiac safety by Khandave, Suhas S, Sawant, Satish V, Sahane, Rakhi V, Murthi, Vivekanand, Dhanure, Shivanand S, Surve, Pradeep G

    “…To study the bioequivalence of Losartan Potassium Tablets 50 mg manufactured by Micro Labs Ltd. India to Cozaar® Tablets 50 mg, manufactured by Merck Sharp and…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: